Tyrosine Kinase Inhibitors Market Set to Witness Robust Growth, Hitting USD 67.62 Bn by 2032
The Global Tyrosine Kinase Inhibitors market reached US$ 51.03 billion in 2023, increased to US$ 53.99 billion in 2024, and is expected to hit US$ 93.97 billion by 2033, growing at a CAGR of 6.4% from 2025 to 2033.   This growth is driven by the rising cancer rates, greater use of precision oncology, and ongoing development in targeted drug creation. The increasing adoption of personalized...
0 Comments 0 Shares 14 Views 0 Reviews
SMG https://sharemeglobal.com